Madden Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.3M Buy
10,109
+523
+5% +$530K 2.8% 9
2025
Q4
$10.3M Buy
9,586
+14
+0.1% +$13.4K 3.14% 9
2025
Q3
$7.3M Buy
9,572
+399
+4% +$297K 2.23% 16
2025
Q2
$7.15M Buy
9,173
+347
+4% +$270K 2.4% 10
2025
Q1
$7.29M Sell
8,826
-65
-0.7% -$54.1K 2.83% 7
2024
Q4
$6.86M Sell
8,891
-725
-8% -$600K 2.75% 9
2024
Q3
$8.52M Sell
9,616
-36
-0.4% -$32.4K 3.67% 6
2024
Q2
$8.74M Buy
9,652
+16
+0.2% +$12.8K 3.87% 5
2024
Q1
$7.5M Buy
9,636
+626
+7% +$446K 3.46% 6
2023
Q4
$5.25M Sell
9,010
-110
-1% -$64.2K 2.78% 9
2023
Q3
$4.9M Sell
9,120
-2,990
-25% -$1.54M 2.77% 12
2023
Q2
$5.68M Sell
12,110
-5,335
-31% -$2.24M 2.91% 8
2023
Q1
$5.99M Buy
17,445
+7,325
+72% +$2.47M 3.17% 8
2022
Q4
$3.7M Buy
+10,120
New +$3.59M 1.95% 15

Other funds holding LLY

Madden Securities's LLY Position: Q1 2026 in Review

Madden Securities increased its Eli Lilly (LLY) stake by 5.5% in Q1 2026, buying an estimated $530K and bringing the position to 10,109 shares worth $9.3M. The position accounts for 2.8% of the portfolio, ranked #9.

Madden Securities first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $10.3M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Madden Securities held 10,109 shares of Eli Lilly worth $9.3M as of Q1 2026.
  • Madden Securities bought 523 Eli Lilly shares in Q1 2026, an estimated $530K.
  • Eli Lilly made up 2.8% of Madden Securities's portfolio in Q1 2026, its #9 holding.
  • Madden Securities first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Madden Securities's Eli Lilly position peaked at $10.3M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Madden Securities's 13F filing for Q1 2026, filed 5 May 2026.